Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Medica Philippina ; : 5-11, 2022.
Artigo em Inglês | WPRIM | ID: wpr-988522

RESUMO

@#Antiphospholipid antibodies (aPL) are commonly found in humans after an infection. Its action can promote thrombosis via the activation of endothelial cells, platelets, and neutrophils. This autoantibody is the leading cause of antiphospholipid antibody syndrome (APS), characterized by widespread thrombosis in various vascular beds. COVID-19 also causes acute ischemic stroke (AIS) in the younger demographic, who previously was not considered a population at risk for AIS, which may be related to APS. This narrative review will discuss the role of aPL in COVID-19 patients who experienced AIS during infection.


Assuntos
AVC Isquêmico , COVID-19 , Síndrome Antifosfolipídica , Anticorpos Antifosfolipídeos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA